Burkehill Global Management »

4d Molecular Therapeutics In shares owned by Burkehill Global Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Burkehill Global Management from 13F filings

Historical chart of Burkehill Global Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Burkehill Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Burkehill Global Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.1M 275k 7.50

More positions owned by Burkehill Global Management

Itt (ITT)
Sofi Technologies (SOFI)
Nasdaq Omx (NDAQ)
Lauder Estee Cos Cl A (EL)
Coreweave Com Cl A (CRWV)
Rollins (ROL)
Standardaero (SARO)
Medline Com Cl A (MDLN)
Realty Income (O)
Galaxy Digital Cl A (GLXY)
Figure Technology Solutio Com Cl A (FIGR)
Viking Holdings Ord Shs (VIK)
Symbotic Class A Com (SYM)
Nebius Group Shs Class A (NBIS)
Loar Holdings Com Shs (LOAR)

View all positions for Burkehill Global Management

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
State Street Corporation
Henderson Group
Federated Investors
Point72 Asset Management
Millennium Management
Armistice Capital
Geode Capital Management
Evergreen Quality Fund GP
Deutsche Bank Aktiengesellschaft

View all funds holding 4d Molecular Therapeutics In